Astrid Ruefli-Brasse

Astrid Ruefli-Brasse has had a successful career in the field of biotechnology and pharmaceuticals. Astrid is currently working at Pfizer as the Vice President of Tumor Biology. Prior to joining Pfizer, they held leadership roles at 23andMe, where they served as the Vice President and Head of Discovery and Translational Research, as well as the Director of Drug Discovery. Before that, they worked at Roche as a Senior Group Leader and Vice Director. Earlier in their career, Astrid was a Principal Scientist at Amgen, where they led a research lab and was involved in the development of small molecule and protein-based therapeutics for oncology. Astrid also served as a Post-doc at Genentech. Astrid's work experience spans over two decades and they have demonstrated expertise in various aspects of cancer research and drug discovery.

Astrid Ruefli-Brasse earned a Bachelor of Arts degree in Biology from the University of Rochester in 1993. Astrid went on to complete their PhD in Cell Biology/Cancer Immunology at the University of Melbourne from 1998 to 2002.